Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GPT Pharmaceuticals is an India-based pharmaceutical manufacturing company focused on formulation intermediates and oral drug-delivery products rather than novel clinical-stage therapeutics. The company specializes in pharmaceutical formulation intermediates, modified-release pellets, taste-masking granules, and directly compressible granules using polymer-based controlled drug-delivery technologies. Its business appears to center on development and manufacturing services for generic and branded formulation supply, including ready-to-fill and ready-to-compress products for a range of active pharmaceutical ingredients. Publicly available information indicates operations in Hyderabad, Telangana, with commercial manufacturing capabilities and listings for products such as domperidone, esomeprazole magnesium, itraconazole, pantoprazole sodium, rabeprazole sodium, and tamsulosin. Based on available evidence, GPT Pharmaceuticals is best characterized as a privately held specialty pharma manufacturer/CDMO-style formulation company rather than a venture-backed biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GPT Pharmaceuticals.